EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gingipain proteases from the bacterium Porphyromonas gingivalis confer protection against airway viral infection

Carlos J Rodriguez Hernandez iD, Alonso Cruz-Cruz iD, Chandra L Shrestha, Marina Terekhova, Phylip Chen, John Perpich iD, Barbara Potempa, Katherine Carey iD, Michelle Rohlfing iD, Mark E Peeples iD, Mitchell H Grayson iD, Jan Potempa und 3 weitere

Proceedings of the National Academy of Sciences · 05.05.2026 · 123 (18)

DOI: 10.1073/pnas.2503100123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 30.04.2026. Verfasst von Carlos J Rodriguez Hernandez und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center for Microbe and Immunity Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 430205. Hauptthemen laut MEDLINE: Porphyromonas gingivalis, Cysteine Endopeptidases, Adhesins, Bacterial, Respiratory Syncytial Virus Infections. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, HHS | NIH | National Institute of Dental and Craniofacial Research (NIDR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Physical interactions with bacterial colonizers at mucosal barrier surfaces can have beneficial or detrimental effects on viral infectivity and transmission. The oropharyngeal mucosal surface is a major portal of entry for many pathogenic respiratory viruses, such as respiratory syncytial virus (RSV), and also harbors a rich and diverse microbiome. Whether oropharyngeal bacteria directly or indirectly influence host susceptibility to respiratory viruses remains unknown. Here, we show that Porphyromonas gingivalis , an oral pathobiont, potently and uniquely suppresses airway epithelial antiviral immunity by degrading interferons (IFNs) and transcriptionally repressing multiple IFN-stimulated genes (ISGs), which are essential for providing resistance to viral infection. Despite inducing a state of IFN hyporesponsiveness, we found that P. gingivalis counterintuitively protected against severe infection by RSV and the closely related murine-specific Sendai virus (SeV) in two independent models: human airway bronchial epithelial transwell cultures and airway infection in mice. This protection was conferred by the activity of P. gingivalis cysteine proteases (gingipains) that cleaved envelope glycoproteins on RSV and SeV, thereby impairing their infectious capacity. Thus, our data show a nuanced role for P. gingivalis in modulating host susceptibility to viral infection. While P. gingivalis can significantly inhibit host IFN responses, its proteases preemptively reduce viral infectious capacity, protecting the host from severe damage associated with respiratory infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Porphyromonas gingivalisCysteine EndopeptidasesAdhesins, BacterialRespiratory Syncytial Virus InfectionsRespirovirus InfectionsAnimalsMiceHumansGingipain Cysteine EndopeptidasesSendai virusInterferonsRespiratory Syncytial VirusesFemale

Stichwörter der Autor:innen

P. gingivalisRSVinterferonperiodontititsviral infection

Substanzen

Gingipain Cysteine EndopeptidasesCysteine EndopeptidasesInterferonsAdhesins, Bacterial

Autor:innen und Institutionen

  • Center for Microbe and Immunity Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 430205.
  • Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO 63110.
  • Department of Oral Immunology and Infectious Diseases, School of Dentistry, University of Louisville, Louisville, KY 40205.
  • Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Sullivan University, Louisville, KY 40205.
  • Center for Clinical and Translational Research, The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 430205.
  • Division of Allergy and Immunology, Department of Pediatrics, Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, OH 430205.

ORCID-Profile: Carlos J Rodriguez Hernandez, Alonso Cruz-Cruz, John Perpich, Katherine Carey, Michelle Rohlfing, Mark E Peeples, Mitchell H Grayson, Richard J Lamont, Juhi Bagaitkar

Förderung

  • NIDCR NIH HHS
  • HHS | NIH | National Institute of Dental and Craniofacial Research (NIDR)

Zitieren

APA

Rodriguez Hernandez, C. J., Cruz-Cruz, A., Shrestha, C. L., Terekhova, M., Chen, P., Perpich, J., Potempa, B., Carey, K., Rohlfing, M., Peeples, M. E., Grayson, M. H., Potempa, J., Artyomov, M., Lamont, R. J., & Bagaitkar, J. (2026). Gingipain proteases from the bacterium Porphyromonas gingivalis confer protection against airway viral infection. Proceedings of the National Academy of Sciences, 123(18). https://doi.org/10.1073/pnas.2503100123

Vancouver

Rodriguez Hernandez CJ, Cruz-Cruz A, Shrestha CL, Terekhova M, Chen P, Perpich J, et al. Gingipain proteases from the bacterium Porphyromonas gingivalis confer protection against airway viral infection. Proceedings of the National Academy of Sciences. 2026;123(18). doi:10.1073/pnas.2503100123

BibTeX
@article{RodriguezHernandez2026,
  author = {Rodriguez Hernandez, Carlos J and Cruz-Cruz, Alonso and Shrestha, Chandra L and Terekhova, Marina and Chen, Phylip and Perpich, John and Potempa, Barbara and Carey, Katherine and Rohlfing, Michelle and Peeples, Mark E and Grayson, Mitchell H and Potempa, Jan and Artyomov, Maxim and Lamont, Richard J and Bagaitkar, Juhi},
  title = {Gingipain proteases from the bacterium Porphyromonas gingivalis confer protection against airway viral infection},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {18},
  doi = {10.1073/pnas.2503100123}
}
Kostenlos starten →